about us
IR Information
May 17, 2010 Financial Results for FY2009
May 17, 2010 Financial Data FY2009
February 12, 2010 Financial Results for the Nine Months of FY2009
February 9, 2010 Financial Data Nine Months FY2009
November 11, 2009 Financial Results for the 1st Half of FY2009
November 6, 2009 Financial Data 1H FY2009
August 10, 2009 Financial Results for the 1st Quarter of FY2009
August 7, 2009 Financial Data 1Q FY2009

Annual Report 2009
May 12, 2009 Medium-term Business Plan 09-11 M1 TRUST FY3/2010-FY3/2012
May 11, 2009 Financial Data FY2008
February 9, 2009 Financial Data 3Q FY2008
February 9, 2009 Financial Results for the 3rd Quarter FY3/2009
November 12, 2008 Financial Results for the 1st Half FY3/2009
November 10, 2008 Financial Data 2Q FY2008
August 18, 2008 Annual Report 2008
June 5, 2008 FY2007 Results and FY2008 Forecasts
June 5, 2008 Financial Data 2008
May 17, 2007 FY2006 Results and FY2007 Forecasts
May 11, 2007 Financial Data 2007
March 22, 2006 Announcement of Organizational Changes and Personnel Transfers
March 13, 2006 Basic agreement on joint efforts to prepare for notification from the MHLW to possess all strengths of generic products
January 31, 2006 Sawai wins lawsuit filed by Eisai concerning our Teprenone product based on Japan's Unfair Competition Prevention Law
January 23, 2006 Notice of third-party allocation of new shares in Medisa Shinyaku Inc.,a subsidiary of Sawai Pharmaceutical, to be allocated to Sumitomo Group
December 1, 2005 Inheritance of the Approval for the Manufacture and Sale of Medical-Use Percutaneous Absorptive Analgesic Antiphlogistics "FALZY"